PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.
Adult
Aged
B-Lymphocytes
/ immunology
CD11c Antigen
/ metabolism
CRISPR-Cas Systems
/ genetics
Case-Control Studies
Cell Communication
/ drug effects
Cell Culture Techniques
Cell Separation
Cells, Cultured
Coculture Techniques
Female
Flow Cytometry
Gene Knockout Techniques
Humans
Interleukins
/ antagonists & inhibitors
Lupus Erythematosus, Systemic
/ blood
Lymphocyte Activation
/ drug effects
Male
Middle Aged
Programmed Cell Death 1 Receptor
/ metabolism
Proto-Oncogene Proteins c-maf
/ genetics
RNA-Seq
Receptors, CXCR5
/ metabolism
T-Lymphocytes, Helper-Inducer
/ immunology
Adaptive immunity
Autoimmunity
Immunology
Lupus
T cells
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
17 10 2019
17 10 2019
Historique:
received:
16
05
2019
accepted:
13
09
2019
pubmed:
20
9
2019
medline:
21
10
2020
entrez:
20
9
2019
Statut:
epublish
Résumé
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathologic T cell-B cell interactions and autoantibody production. Defining the T cell populations that drive B cell responses in SLE may enable design of therapies that specifically target pathologic cell subsets. Here, we evaluated the phenotypes of CD4+ T cells in the circulation of 52 SLE patients drawn from multiple cohorts and identified a highly expanded PD-1hiCXCR5-CD4+ T cell population. Cytometric, transcriptomic, and functional assays demonstrated that PD-1hiCXCR5-CD4+ T cells from SLE patients are T peripheral helper (Tph) cells, a CXCR5- T cell population that stimulates B cell responses via IL-21. The frequency of Tph cells, but not T follicular helper (Tfh) cells, correlated with both clinical disease activity and the frequency of CD11c+ B cells in SLE patients. PD-1hiCD4+ T cells were found within lupus nephritis kidneys and correlated with B cell numbers in the kidney. Both IL-21 neutralization and CRISPR-mediated deletion of MAF abrogated the ability of Tph cells to induce memory B cell differentiation into plasmablasts in vitro. These findings identify Tph cells as a highly expanded T cell population in SLE and suggest a key role for Tph cells in stimulating pathologic B cell responses.
Identifiants
pubmed: 31536480
pii: 130062
doi: 10.1172/jci.insight.130062
pmc: PMC6824311
doi:
pii:
Substances chimiques
CD11c Antigen
0
CXCR5 protein, human
0
Interleukins
0
MAF protein, human
0
PDCD1 protein, human
0
Programmed Cell Death 1 Receptor
0
Proto-Oncogene Proteins c-maf
0
Receptors, CXCR5
0
interleukin-21
MKM3CA6LT1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : K08 AR072791
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR065538
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070253
Pays : United States
Références
Diabetologia. 2019 Sep;62(9):1681-1688
pubmed: 31270583
J Immunol. 2016 Aug 15;197(4):1023-8
pubmed: 27430719
Nature. 2019 Jul;571(7763):122-126
pubmed: 31189952
J Exp Med. 2010 Feb 15;207(2):365-78
pubmed: 20142430
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Arthritis Rheumatol. 2015 Oct;67(10):2723-31
pubmed: 26097207
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7932-7
pubmed: 21518858
Sci Transl Med. 2014 Apr 2;6(230):230ra46
pubmed: 24695686
Science. 2009 Aug 21;325(5943):1001-5
pubmed: 19628815
Arthritis Rheum. 2011 Jan;63(1):63-72
pubmed: 20882667
Nat Immunol. 2015 Jul;16(7):755-65
pubmed: 26006014
J Immunol. 2017 Apr 1;198(7):2578-2588
pubmed: 28219887
Lupus. 2015 Aug;24(9):909-17
pubmed: 25654980
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
J Immunol. 2012 Apr 15;188(8):3734-44
pubmed: 22427637
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Front Immunol. 2018 Mar 05;9:427
pubmed: 29556239
J Clin Invest. 2019 Jul 2;129(8):3185-3200
pubmed: 31264971
Immunity. 2013 Oct 17;39(4):770-81
pubmed: 24138884
Nat Med. 2019 Jan;25(1):75-81
pubmed: 30478422
Nat Commun. 2016 Feb 26;7:10875
pubmed: 26915335
Immunol Rev. 2016 Jan;269(1):118-29
pubmed: 26683149
J Immunol. 2009 Feb 1;182(3):1421-8
pubmed: 19155489
Nat Protoc. 2015 Feb;10(2):316-33
pubmed: 25612231
Nat Immunol. 2019 Jul;20(7):915-927
pubmed: 31110316
Nature. 2005 May 26;435(7041):452-8
pubmed: 15917799
Arthritis Rheumatol. 2015 Apr;67(4):988-99
pubmed: 25581113
Arthritis Rheum. 2002 Oct 15;47(5):546-55
pubmed: 12382306
Nat Commun. 2018 May 1;9(1):1758
pubmed: 29717110
J Immunol. 2011 Feb 1;186(3):1849-60
pubmed: 21187439
Cytometry A. 2013 May;83(5):483-94
pubmed: 23512433
Arthritis Rheum. 2010 Jan;62(1):234-44
pubmed: 20039395
J Exp Med. 2008 Nov 24;205(12):2873-86
pubmed: 18981236
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Immunity. 2018 Oct 16;49(4):725-739.e6
pubmed: 30314758
Arthritis Rheumatol. 2014 Jun;66(6):1583-95
pubmed: 24644022
Front Immunol. 2018 Aug 23;9:1924
pubmed: 30190721
J Clin Invest. 2015 Jan;125(1):292-303
pubmed: 25485678
J Immunol. 2001 Aug 15;167(4):2361-9
pubmed: 11490026
Nat Immunol. 2018 Apr;19(4):407-419
pubmed: 29483597
Nat Immunol. 2019 Jul;20(7):902-914
pubmed: 31209404
Cell. 2016 Apr 21;165(3):551-65
pubmed: 27040498
Arthritis Rheum. 2003 May;48(5):1332-42
pubmed: 12746906
Eur J Immunol. 2016 Feb;46(2):281-90
pubmed: 26614103
Nat Commun. 2017 Aug 15;8(1):254
pubmed: 28811467
Immunity. 2018 Dec 18;49(6):1034-1048.e8
pubmed: 30566881
Nat Med. 2019 May;25(5):734-737
pubmed: 30911136
Cell Syst. 2018 May 23;6(5):612-620.e5
pubmed: 29605184